On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

Allan M. Skene

ResearcherPublications, citations & collaboration network

Allan M. Skene is a researcher indexed in ScholarIQ from OpenAlex & ORCID.

How many works does Allan M. Skene have?

ScholarIQindexed works

Allan M. Skene has 41 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Allan M. Skene have?

ScholarIQcitation count

Allan M. Skene has 24,852 citations in the OpenAlex counts ScholarIQ stores.

What is the h-index of Allan M. Skene?

ScholarIQh-index

Allan M. Skene has an h-index of 28 in OpenAlex.

What is the i10-index of Allan M. Skene?

ScholarIQi10-index

Allan M. Skene has an i10-index of 34 in OpenAlex.

What is the OpenAlex record for Allan M. Skene?

ScholarIQopenalex

The OpenAlex for Allan M. Skene is on the source record.

What are the most-cited papers on Allan M. Skene?

ScholarIQmost cited works
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
Lars Wallentin, Richard C. Becker, Andrzej Budaj, Christopher P. Cannon, Håkan Emanuelsson, Claes Held, Jay Horrow, Steen Husted, Stefan James, Hugo A. Katus, Kenneth W. Mahaffey, Benjamin M. Scirica, Allan M. Skene, Philippe Gabríel Steg, Robert F. Storey, Robert A. Harrington
New England Journal of Medicine. 20097,106 CitationsOPEN ACCESS
Intensive versus Moderate Lipid Lowering with Statins after Acute Coronary Syndromes
Christopher P. Cannon, Eugene Braunwald, Carolyn H. McCabe, Daniel J. Rader, Jean L. Rouleau, René Belder, Steven Joyal, Karen A. Hill, Marc A. Pfeffer, Allan M. Skene
New England Journal of Medicine. 20044,953 CitationsOPEN ACCESS
Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial
John Dormandy, B Charbonnel, D.J.A. Eckland, Erland Erdmann, Massimo Massi‐Benedetti, Ian K. Moules, Allan M. Skene, Meng H. Tan, Pierre J. Lefèbvre, Gordon Murray, Eberhard Standl, Robert G. Wilcox, Lars Wilhelmsen, John Betteridge, Kåre I. Birkeland, Alain Golay, Robert J. Heine, László Korányi, Markku Laakso, Marian Mokáň, Antanas Norkus, Valdis Pīrāgs, Toomas Podar, André Scheen, Werner A. Scherbaum, Guntram Schernthaner, Ole Schmitz, J Skrha, Ulf Smith, J Tatoń
The Lancet. 20054,139 CitationsOPEN ACCESS
Addition of Clopidogrel to Aspirin and Fibrinolytic Therapy for Myocardial Infarction with ST-Segment Elevation
Marc S. Sabatine, Christopher P. Cannon, C. Michael Gibson, José Luís López-Sendón, Gilles Montalescot, Pierre Théroux, Marc J. Claeys, Frank Cools, Karen A. Hill, Allan M. Skene, Carolyn H. McCabe, Eugene Braunwald
New England Journal of Medicine. 20051,924 Citations
Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial
Philip A. Poole‐Wilson, Karl Swedberg, John G.F. Cleland, Andrea Di Lenarda, Peter Hanrath, Michel Komajda, Jacobus Lubsen, Beatrix Lutiger, Marco Metra, Willem J. Remme, Christian Torp‐Pedersen, Armin Scherhag, Allan M. Skene
The Lancet. 20031,873 CitationsOPEN ACCESS

Related on ScholarIQ

470M+ articles · free account